Argenx FB102 meets Phase 2 celiac endpoint
Health — broke 23h · updated 17h
7 covering Argenx Phase 2 FB102 trial in 126 celiac adults met the primary endpoint (Vh:Cd p=0.0176); firm plans Phase 3. Same day it halted the Sjögren's UNITY study.
Health — broke 23h · updated 17h
7 covering Argenx Phase 2 FB102 trial in 126 celiac adults met the primary endpoint (Vh:Cd p=0.0176); firm plans Phase 3. Same day it halted the Sjögren's UNITY study.

Spain approved changes to its olive-oil quality standards to strengthen traceability, authenticity and consumer confidence. Separately, research highlighted a consumer misconception that sweeter-tasting olive oil is healthier, while bitterness in fresh extra-virgin oil can reflect beneficial polyphenols.





